Tech Company Financing Transactions
Vigilant Biosciences Funding Round
Vigilant Biosciences, based in Ft. Lauderdale, secured $2 million from private investors.
Transaction Overview
Company Name
Announced On
3/26/2014
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds will support 510(k) clearance and CE Mark approval efforts while enabling the company to prepare for international product launch and to simultaneously advance other products in its pipeline.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
6301 NW 5th Way 1500
Ft. Lauderdale, FL 33309
USA
Ft. Lauderdale, FL 33309
USA
Phone
Website
Email Address
Overview
Vigilant Biosciences is a leading innovator and developer of solutions that aid in the early detection and intervention of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Brodie
Chief Financial Officer
Robert Hamilton
Chief Medical Officer
Michael Donovan
Chief Scientific Officer
Elizabeth Franzmann
VP - Operations
Tony Lavecchia
VP - Regulatory Affairs
Kris Foss
Browse more venture capital transactions:
Prev: 3/26/2014: TouchBistro venture capital transaction
Next: 3/26/2014: Circle venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs